Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Serum neuroleptic levels were measured by radioreceptor assay in patients treated with the antidepressant amoxapine. When compared to standard neuroleptics, amoxapine produced relatively weak neuroleptic activity. Amoxapine dose correlated significantly with serum neuroleptic level. Three of eight patients developed significant extrapyramidal side effects. Neither dose of amoxapine nor neuroleptic level correlated with the presence or severity of EPS.
Gaffney
G R
GR
Tune
L E
LE
D000328:Adult; D000657:Amoxapine / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000097:blood*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D003989:Dibenzoxazepines / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D019964:Mood Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D003989:Dibenzoxazepines; D008094:Lithium; D000657:Amoxapine